Old Web
English
Sign In
Acemap
>
authorDetail
>
Ching-Fai Pang
Ching-Fai Pang
University of Missouri
in patient
Cancer research
dose escalation
anti cd20
B cell
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1 Dose Escalation Study of Igm-2323, a Novel Anti-CD20 x Anti-CD3 IgM T Cell Engager (TCE) in Patients with Advanced B-Cell Malignancies
2021
Blood
Elizabeth Budde
Ajay K. Gopal
Won-Seog Kim
Ian W. Flinn
Chan Yoon Y. Cheah
Loretta J. Nastoupil
Matthew J. Matasar
Catherine Diefenbach
Gareth P. Gregory
Ibrahim Qazi
Ching-Fai Pang
Maya Leabman
Genevive Hernandez
Iris Sison
Bruce Keyt
Daniel S. Chen
Philippe Armand
Show All
Source
Cite
Save
Citations (0)
Preliminary Results of a Phase 1 Dose Escalation Study of the First-in-Class IgM Based Bispecific Antibody Igm-2323 (anti-CD20 x anti-CD3) in Patients with Advanced B-Cell Malignancies
2020
Blood
Elizabeth Budde
Ajay K. Gopal
Ian W. Flinn
Loretta J. Nastoupil
Michael S. Gordon
Ching-Fai Pang
Bruce Keyt
Steve Carroll
Maya Leabman
Genevive Hernandez
I. Sison
Daniel S. Chen
Wayne R. Godfrey
Philippe Armand
Show All
Source
Cite
Save
Citations (2)
Maximum likelihood estimation of convex arrival rate
1989
Biometrika
Ching-Fai Pang
W.A. Thompson
Hamid Fallahi
Show All
Source
Cite
Save
Citations (0)
1